Phil Deschamps, CEO for Helius Medical Technologies, Revolutionizing Brain Trauma Treatments

Everett Jolly Interviews Phil Deschamps, CEO of Helius Medical Technologies, Inc. (OTC: HSDT / TSXV: HSM) and they discuss their therapy trials to assist with traumatic brain injuries.



We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.

Leave a Reply